{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:53:06Z","timestamp":1790805186979,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10354-018-0667-6","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T14:02:54Z","timestamp":1541599374000},"page":"193-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage)","Lippencreme mit 0,5\u202f% Propolis-Spezialextrakt GH 2002 versus 5\u202f% Aciclovir bei Herpes labialis (Bl\u00e4schenstadium)"],"prefix":"10.1007","volume":"169","author":[{"given":"Jagienka","family":"Jautov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Zelenkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Drotarov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Nejdkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017eena","family":"Gr\u00fcnwaldov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hladikov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"667_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-3-662-48678-8_71","volume-title":"Medizinische Mikrobiologie und Infektionlogie","author":"B Sodeik","year":"2016","unstructured":"Sodeik B, Messerle M, Schulz TF. Herpesviren. In: Suerbaum S, Burchard G\u2011D, Kaufmann SHE, Schulz TF, editors. Medizinische Mikrobiologie und Infektionlogie. 8th\u00a0ed. Heidelberg: Springer; 2016. pp. 553\u201372.","edition":"8"},{"key":"667_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/b137790","volume-title":"Dermatologie und Venerologie","author":"O Braun-Falco","year":"2005","unstructured":"Braun-Falco O, Plewig G, Wolf HH, et al. Dermatologie und Venerologie. Heidelberg: Springer; 2005."},{"key":"667_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/infdis\/146.1.85","volume":"146","author":"SL Spruance","year":"1982","unstructured":"Spruance SL, Schnipper LE, Overall JC Jr., et\u00a0al. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J\u00a0Infect Dis. 1982;146:85\u201390.","journal-title":"J Infect Dis"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/0030-4220(89)90007-8","volume":"67","author":"GW Raborn","year":"1989","unstructured":"Raborn GW, McGaw WT, Grace M, et al. Herpes labialis treatment with acyclovir 5\u202f% modified aqueous cream: a\u00a0double-blind randomized trial. Oral Surg Oral Med Oral Pathol. 1989;67:676\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"667_CR5","first-page":"1653","volume":"145","author":"G Patz","year":"2006","unstructured":"Patz G, Gross G. Aciclovir Creme bei Lippenherpes. Dtsch Apoth Z. 2006;145:1653\u20138.","journal-title":"Dtsch. Apoth. Z."},{"key":"667_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1001\/jama.1997.03540410052030","volume":"277","author":"SL Spruance","year":"1997","unstructured":"Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 1997;277:1374\u20139.","journal-title":"JAMA"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1079-2104(99)70164-2","volume":"87","author":"E Horwitz","year":"1999","unstructured":"Horwitz E, Pisanty S, Czerninski R, et\u00a0al. A clinical evaluation of a\u00a0novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:700\u20135.","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"667_CR8","first-page":"100","volume":"33","author":"S Holcov\u00e1","year":"2012","unstructured":"Holcov\u00e1 S, Hladikov\u00e1 M. Inhibition of the development of cold sores through early use of a\u00a0nursing lip balm containing the active constituent propolis special extract GH 2002 in comparison with aciclovir cream 5\u202f% (in German). Kosmet Med. 2012;33:100\u20134.","journal-title":"Kosmet Med"},{"key":"667_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2017.10.004","volume":"88","author":"P Arenberger","year":"2018","unstructured":"Arenberger P, Arenbergerova M, Hladikova M, et al. Comparative study with a\u00a0lip balm containing 0.5\u202f% Propolis special extract GH 2002 versus 5\u202f% aciclovir cream in patients with herpes labialis in the papular\/erythematous stage: a single-blind, randomized, two-arm study. Curr Ther Res Clin Exp. 2018;88:1\u20137.","journal-title":"Curr Ther Res Clin Exp"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1002\/ptr.2868","volume":"24","author":"P Schnitzler","year":"2010","unstructured":"Schnitzler P, Neuner A, Nolkemper S, et\u00a0al. Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother Res. 2010;24:S20\u2013S8.","journal-title":"Phytother Res"},{"key":"667_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.phymed.2009.07.006","volume":"17","author":"S Nolkemper","year":"2010","unstructured":"Nolkemper S, Reichling J, Sensch KH, et\u00a0al. Mechanism of herpes simplex virus type 2 suppression by propolis extracts. Phytomedicine. 2010;17:132\u20138.","journal-title":"Phytomedicine"},{"key":"667_CR12","first-page":"695","volume":"68","author":"A Astani","year":"2013","unstructured":"Astani A, Zimmermann S, Hassan E, et al. Antimicrobial activity of propolis special extract GH 2002 against multidrug-resistant clinical isolates. Pharmazie. 2013;68:695\u2013701.","journal-title":"Pharmazie"},{"key":"667_CR13","unstructured":"Anon. Propolis. In: Krell R, editor. Value-added products from beekeeping. FAO Agricultural Services Bulletin 124. Rome: Food and Agricultural Organisation of the United Nations; 1996."},{"key":"667_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/0005772X.1979.11097738","volume":"60","author":"EL Ghisalberti","year":"1979","unstructured":"Ghisalberti EL. Propolis: a\u00a0review. Bee World. 1979;60:59\u201384.","journal-title":"Bee World"},{"key":"667_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1051\/apido:19950202","volume":"26","author":"MC Marcucci","year":"1995","unstructured":"Marcucci MC. Propolis: Chemical composition, biological properties and therapeutic activity. Apidologie (Celle). 1995;26:83\u201399.","journal-title":"Apidologie (Celle)"},{"key":"667_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1051\/apido:2000102","volume":"31","author":"VS Bankova","year":"2000","unstructured":"Bankova VS, de Castro LE, Marcucci MC. Propolis: Recent advances in the chemistry and plant origin. Apidologie (Celle). 2000;31:3\u201315.","journal-title":"Apidologie (Celle)"},{"key":"667_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1021\/np980028c","volume":"61","author":"AH Banskota","year":"1998","unstructured":"Banskota AH, Tezuka Y, Prasain JK, et\u00a0al. Chemical constituents of Brazilian propolis and their cytotoxic activities. J\u00a0Nat Prod. 1998;61:896\u2013900.","journal-title":"J Nat Prod"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1515\/znc-1996-5-602","volume":"51","author":"V Bankova","year":"1996","unstructured":"Bankova V, Marcucci MC, Simova S, et\u00a0al. Antibacterial diterpenic acids from Brazilian propolis. Z\u00a0Naturforsch\u00a0C. 1996;51:277\u201380.","journal-title":"Z Naturforsch C"},{"key":"667_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/0005772X.1990.11099047","volume":"71","author":"W Greenaway","year":"1990","unstructured":"Greenaway W, Scaysbrook T, Whatley FR. The composition and plant origins of propolis: a report of work at oxford. Bee World. 1990;71:107\u201318.","journal-title":"Bee World"},{"key":"667_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/znc-1989-11-1231","volume":"44","author":"S Scheller","year":"1989","unstructured":"Scheller S, Krol W, Swiacik J, et al. Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin. Z\u00a0Naturforsch\u00a0C. 1989;44:1063\u20135.","journal-title":"Z Naturforsch C"},{"key":"667_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF01941717","volume":"44","author":"D Grunberger","year":"1988","unstructured":"Grunberger D, Banerjee R, Eisinger K, et\u00a0al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia. 1988;44:230\u20132.","journal-title":"Experientia"},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0378-8741(94)90052-3","volume":"41","author":"C Pascual","year":"1994","unstructured":"Pascual C, Gonzalez R, Torricella RG. Scavenging action of propolis extract against oxygen radicals. J\u00a0Ethnopharmacol. 1994;41:9\u201313.","journal-title":"J Ethnopharmacol"},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-8741(98)00131-7","volume":"64","author":"A Kujumgiev","year":"1999","unstructured":"Kujumgiev A, Tsetkova I, Serkedjieva J, et\u00a0al. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J\u00a0Ethnopharmacol. 1999;64:235\u201340.","journal-title":"J. Ethnopharmacol."},{"key":"667_CR24","first-page":"785","volume":"48","author":"A Kujumgiev","year":"1993","unstructured":"Kujumgiev A, Bankova V, Ignatova A, et\u00a0al. Antibacterial activity of propolis, some of its components and their analogs. Pharmazie. 1993;48:785\u20136.","journal-title":"Pharmazie"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ptr.1029","volume":"15","author":"AH Banskota","year":"2001","unstructured":"Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res. 2001;15:561\u201371.","journal-title":"Phytother Res"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0278-6915(97)00145-2","volume":"36","author":"GA Burdock","year":"1998","unstructured":"Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol. 1998;36:347\u201363.","journal-title":"Food. Chem. Toxicol."},{"key":"667_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0308-8146(02)00231-5","volume":"80","author":"T Nagai","year":"2003","unstructured":"Nagai T, Inoue R, Inoue H, et\u00a0al. Preparation and antioxidant properties of water extract of propolis. Food Chem. 2003;80:29\u201333.","journal-title":"Food Chem"},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1211\/0022357021779023","volume":"54","author":"N Paulino","year":"2002","unstructured":"Paulino N, Scremin FM, Raichaski LB, et al. Mechanisms involved in the relaxant action of the ethanolic extract of propolis in the guinea-pig trachea in-vitro. J\u00a0Pharm Pharmacol. 2002;54:845\u201352.","journal-title":"J Pharm Pharmacol"},{"key":"667_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4236\/health.2011.31010","volume":"3","author":"S Holcov\u00e1","year":"2011","unstructured":"Holcov\u00e1 S, Hladikov\u00e1 M. Efficacy and tolerability of propolis special extract GH 2002 as a\u00a0lip balm against herpes labialis: a\u00a0randomized, double-blind three-arm dose finding study. Health. 2011;3:49\u201356.","journal-title":"Health"},{"key":"667_CR30","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.4236\/health.2017.910097","volume":"9","author":"D Tomanova","year":"2017","unstructured":"Tomanova D, Holcova S, Hladikova M. Clinical study: lotion containing propolis special extract GH 2002 0.5\u202f% vs. placebo as on-top treatment of herpes zoster. Health. 2017;9:1337\u201347.","journal-title":"Health"},{"key":"667_CR31","first-page":"100","volume":"33","author":"S Holcov\u00e1","year":"2012","unstructured":"Holcov\u00e1 S, Hladikov\u00e1 M. Inhibierung der Entwicklung von Lippenbl\u00e4schen durch fr\u00fchzeitige Anwendung eines pflegenden Lippenbalsams mit derm Wirkstoff Propolis Spezialextrakt GH 2002 im Vergleich mit Aciclovircreme 5. Kosmet Med. 2012;33:100\u20134.","journal-title":"Kosmet Med"},{"key":"667_CR32","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1128\/AAC.46.7.2238-2243.2002","volume":"46","author":"SL Spruance","year":"2002","unstructured":"Spruance SL, Nett R, Marbury T, et al. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002;46:2238\u201343.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-018-0667-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:27:19Z","timestamp":1573086439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-018-0667-6"}},"subtitle":["Randomized, controlled double-blind study","Randomisierte, kontrollierte Doppelblindstudie"],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":32,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s10354-018-0667-6","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"J.\u00a0Jautov\u00e1, H.\u00a0Zelenkov\u00e1, K.\u00a0Drotarov\u00e1, A.\u00a0Nejdkov\u00e1, B.\u00a0Gr\u00fcnwaldov\u00e1, and M.\u00a0Hladikov\u00e1 declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was registered under EudraCT No. 2012-004372-19 and performed in accordance with the Declaration of Helsinki\/Edinburgh and followed ICH-GCP guidelines. Agreement from all ethics committees presiding over the trial centers was obtained. The acceptance of the relevant state authorities (SUKL in Bratislava [Slovakian Drug Authorization Authority]) was also obtained. Written consent was obtained from all patients after information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}